Technical Perspectives: Antibody Drug Conjugates

A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Dec 07, 2011

Antibody drug conjugates represent a niche area of drug development. Antibody drug conjugates combine a small-molecule, often a cytotoxic compound, to a monoclonal antibody. Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor of Pharmaceutical Technology. Listen to the podcast.